Business
Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting
SEATTLE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered
About this update from Sana Biotechnology, Inc.
[{"type":"text","content":"SEATTLE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that five abstracts will have poster presentations at the 65th American Society of Hematology Annual Meeting to be held December 9-12, 2023 in San Diego, CA. Details of the poster presentations are as follows: Title:Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell TherapyAbstract Number:3437Session Name:703. Cellular Immunotherapies: Basic and Translational: Poster IISession Date:Sunday, December 10, 2023Presentation Time:6:00 PM - 8:00 PMLocation:San Diego Convention Center, Halls G-H Title:Efficient and Specific In Vivo Genetic Engineering of Human Hematopoietic Stem Progenitor Cells without Selective ConditioningAbstract Number:2252Session Name:801. Gene Therapies: Poster ISession Date:Saturday, December 9, 2023Presentation Time:5:30 PM - 7:30 PMLocation:San Diego Convention Center, Halls G-H Title:Development of a Novel, Allogeneic GPRC5D-Directed CAR for Treatment of Multiple Myeloma PatientsAbstract Number:3290Session Name:651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster IISession Date:Sunday, December 10, 2023Presentation Time:6:00 PM - 8:00 PMLocation:San Diego Convention Center, Halls G-H Title:In Vitro and In Vivo Specificity and Biodistribution of a Novel CD8-Targeted FusosomeAbstract Number:3630Session Name:801. Gene Therapies: Poster IISession Date:Sunday, December 10, 2023Presentation Time:6:00 PM - 8:00 PMLocation:San Diego Convention Center, Halls G-H Title:Feasibility of Extracorporeal Delivery of Fusosomes to Generate CAR T Cells In VivoAbstract Number:3631Session Name:801. Gene Therapies: Poster IISession Date:Sunday, December 10, 2023Presentation Time:6:00 PM - 8:00 PMLocation:San Diego Convention Center, Halls G-H Full abstracts are available for online viewing via the ASH Annual Meeting website at Hematology.org. About Sana BiotechnologySana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of controlling genes, replacing missing or damaged cells, and making our therapies b...